http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013091595-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fece74aa8c0cb73d997c194165159cc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 |
| filingDate | 2012-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc24df50981592f309d7bf26f0ab6623 |
| publicationDate | 2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2013091595-A1 |
| titleOfInvention | Pharmaceutical formulation of prasugrel hydrobromide |
| abstract | A pharmaceutical composition in the form of coated tablets containing as the active substance prasugrel hydrobromide form C, which exhibits the following characteristic reflections in an X-ray pattern: 8.0; 14.5; 22.0; 27.1 and 29.9° 2θ, measured using CuKα radiation. The composition consists of prasugrel hydrobromide form C in an amount of 3 to 20% by weight, mannitol in an amount of 85 to 5% by weight, a disintegrant in an amount of 1 to 20% by weight, a lubricant in an amount of 5 to 0% by weight, a filler in an amount of 5 to 50% by weight and a coating in an amount of 1 to 5% of the total weight of a tablet. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016203018-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107961221-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104370934-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104370934-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3106151-A1 |
| priorityDate | 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.